Merck Invests €6.6 Million to Expand Cell Culture Media Production at Nantong Site

€ 6.6 million investment at Nantong site expands production capabilities for cell culture media  Supports local biopharma manufact...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Thermo Fisher Scientific Finalizes $3.1 Billion Acquisition of Olink, Ushering in a New Era in Proteomics

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, has announced the successful completion of ...

July 11, 2024 | Thursday | News
Twist Bioscience Expands High-Throughput Antibody Portfolio with Launch of CHO Cell Line for Faster Turnaround Times

Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starti...

July 11, 2024 | Thursday | News
Daiichi Sankyo Expands European Presence with New Oncology Affiliate in Greece

Daiichi Sankyo  announced that it has opened a new affiliate for its oncology business in Athens, Greece. The establishment highlights the company&r...

July 10, 2024 | Wednesday | News
Myricx Bio Secures £90m Series A Funding Co-Led by Novo Holdings and Abingworth

£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...

July 08, 2024 | Monday | News
Roche's Vabysmo® Prefilled Syringe Gains FDA Approval for Major Eye Conditions

Roche  announced  that the United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose pre...

July 05, 2024 | Friday | News
Boehringer Ingelheim and OSE Immunotherapeutics Advance SIRPα Immuno-Oncology Program to Phase 1b Clinical Trials

Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company (ISIN: FR0012127173; Mnemo: OSE), announced that Boehringer wi...

July 04, 2024 | Thursday | News
CSL Behring Achieves European Milestone with First Real-World Treatments of Hemophilia B Using HEMGENIX® Gene Therapy

Global biotechnology leader CSL Behring  announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...

July 04, 2024 | Thursday | News
Samsung Bioepis Receives FDA Approval for PYZCHIVA® as Biosimilar to Stelara for Multiple Inflammatory Conditions

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...

July 01, 2024 | Monday | News
Bio-Rad Laboratories Launches New Anti-Idiotypic and Anti-MMAE Antibodies for Enhanced Bioanalytical Assays

  Bio-Rad Laboratories,  a global leader in life science research and clinical diagnostics products, today launched four new anti-idiotypic anti...

June 25, 2024 | Tuesday | News
Lantheus to Invest A$7.5 Million in Radiopharm Theranostics, Securing Rights to Preclinical Assets

Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in Radiopharm Offer price for the shares of A$0.05 represents a 47...

June 21, 2024 | Friday | News
Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
Illumina Launches DRAGEN™ v4.3, Pioneering Breakthroughs in Genome Analysis

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of DRAGEN™ v4.3, the latest ...

June 12, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in